NewSquare Capital’s Ionis Pharmaceuticals IONS Stock Holding History

NewSquare Capital’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-345	Closed	-$13K	–	387
2016 Q3	$13K	Hold	345	–	–	﹤0.01%	238
2016 Q2	$8K	Sell	345 -46	-12%	-$1.48K	﹤0.01%	266
2016 Q1	$16K	Buy	391 +374	+2,200%	+$15.2K	﹤0.01%	249
2015 Q4	$1K	Hold	17	–	–	﹤0.01%	332
2015 Q3	$1K	Hold	17	–	–	﹤0.01%	305
2015 Q2	$1K	Hold	17	–	–	﹤0.01%	333
2015 Q1	$1K	Hold	17	–	–	﹤0.01%	305
2014 Q4	$1K	Hold	17	–	–	﹤0.01%	310
2014 Q3	$1K	Hold	17	–	–	﹤0.01%	315
2014 Q2	$1K	Buy	+17	New	+$535	﹤0.01%	272

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NewSquare Capital's IONS Position: Q4 2016 in Review

NewSquare Capital sold out of Ionis Pharmaceuticals (IONS) in Q4 2016, closing a stake of 345 shares — an estimated $13K sold.

NewSquare Capital first reported a position in IONS in Q2 2014 and held it in 10 quarters. The position peaked at $16K in Q1 2016. 308 funds tracked by Wall St. Rank hold IONS as of Q4 2016.

NewSquare Capital reported no remaining Ionis Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
NewSquare Capital sold 345 Ionis Pharmaceuticals shares in Q4 2016, an estimated $13K.
NewSquare Capital first reported a position in Ionis Pharmaceuticals in Q2 2014 and held it in 10 quarters.
NewSquare Capital's Ionis Pharmaceuticals position peaked at $16K in Q1 2016.
308 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2016.

Based on NewSquare Capital's 13F filing for Q4 2016, filed 1 Feb 2017.